US BANCORP \DE\ - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$211,442
-24.8%
6,687
-3.1%
0.00%
Q2 2023$281,342
+7.1%
6,899
-2.1%
0.00%
Q1 2023$262,754
+16.5%
7,050
+9.0%
0.00%
Q4 2022$225,564
-66.5%
6,465
-46.3%
0.00%
-100.0%
Q3 2022$673,000
+49.9%
12,040
+38.5%
0.00%0.0%
Q2 2022$449,000
-59.3%
8,695
-42.8%
0.00%
-50.0%
Q1 2022$1,104,000
-36.3%
15,203
+3.8%
0.00%
-33.3%
Q4 2021$1,732,000
+0.5%
14,645
+14.0%
0.00%0.0%
Q3 2021$1,723,000
-6.7%
12,845
+12.7%
0.00%0.0%
Q2 2021$1,846,000
+281.4%
11,401
+89.2%
0.00%
+200.0%
Q1 2021$484,000
+1208.1%
6,026
+792.7%
0.00%
Q4 2020$37,000
-37.3%
675
-77.3%
0.00%
Q3 2020$59,000
-48.7%
2,975
-45.7%
0.00%
Q2 2020$115,000
+173.8%
5,475
+57.6%
0.00%
Q1 2020$42,000
+1300.0%
3,475
+1885.7%
0.00%
Q4 2019$3,000
+50.0%
1750.0%0.00%
Q3 2019$2,000
-33.3%
1750.0%0.00%
Q2 2019$3,0000.0%1750.0%0.00%
Q1 2019$3,000
+50.0%
1750.0%0.00%
Q4 2018$2,000
-60.0%
1750.0%0.00%
Q3 2018$5,0001750.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders